Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Flexible manufacturing OEM & ODM Indonesia

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Arch support insole OEM from China

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Taiwan graphene product OEM factory

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Graphene insole OEM factory Indonesia

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Taiwan neck support pillow OEM factory

Microalgae cultivation facility along the Kona Coast of Hawaii’s Big Island. Image provided by the Cyanotech Corporation. Credit: Greene, C.H., C.M. Scott-Buechler, A.L.P. Hausner, Z.I. Johnson, X. Lei, and M.E. Huntley. 2022. Transforming the future of marine aquaculture: A circular economy approach. Oceanography, p. 28, doi.org/10.5670/oceanog.2022.213, CC-BY 4.0 A new article proposes algae aquaculture as an eco-friendly alternative to traditional farming. Rich in nutrients, microalgae could meet food demands sustainably, though it faces economic challenges without government aid. Terrestrial agriculture provides the backbone of the world’s food production system. A new opinion article published in the open-access journal PLOS Biology makes the case for increased investment in algae aquaculture systems as a means of meeting nutritional needs while reducing the ecological footprint of food production. Authored by Charles H. Greene at University of Washington, Friday Harbor, Washington, and Celina M. Scott-Buechler at Stanford University, Palo Alto, California, the article was published on October 17. Detrimental impacts on climate, land use, freshwater resources, and biodiversity would result from increasing agriculture and fisheries production to meet consumer demand. In their article, the authors argue for shifting the focus of marine aquaculture down the food chain to algae. This could potentially supply the growing demand for nutritious food in addition to reducing the current food system’s ecological footprint. Charles Greene. Credit: Charles Greene, CC BY 4.0 Nutritional Potential of Microalgae Microalgae could provide high amounts of nutritional protein and essential amino acids, in addition to other micronutrients, such as vitamins and antioxidants. Moreover, a marine microalgae-based aquaculture industry would not require arable land and freshwater, or pollute freshwater and marine ecosystems through fertilizer runoff. The article does not address the potential for a new algae-based aquaculture industry to be culturally responsive, how large-scale microalgae production would affect local foodways, or how algae tastes. According to the authors, “The financial headwinds faced by a new marine microalgae-based aquaculture industry will be stiff because it must challenge incumbent industries for market share before its technologies are completely mature and it can achieve the full benefits of scale. Financial investments and market incentives provided by state and federal governments can help reduce this green premium until the playing field is level. The future role of algae-based solutions in achieving global food security and environmental sustainability will depend on the actions taken by governments today.” Greene adds, “Agriculture provides the backbone of today’s global food production system; however, its potential to meet the world’s nutritional demands by 2050 is limited. Marine microalgae can help fill the projected nutritional gap while simultaneously improving overall environmental sustainability and ocean health.” Interview with Associate Director for Research and Strategic Planning Dr. Charles H. Greene What first drew you to study microalgae and sustainability? About a dozen years ago, I came to the conclusion that too many Earth scientists were focusing only on the impacts of climate change and not looking for solutions to the problem. A colleague of mine, Dr. Mark Huntley, invited me to join his team investigating the potential of marine microalgae in the production of biofuels. Over time, our thinking evolved, and we realized that marine microalgae have tremendous potential for addressing the global challenges of food and water security, climate change, and many other aspects of environmental sustainability. What are the key findings you collected in your paper? By taking an integrated, circular economy approach to cultivating marine microalgae, we can close the gap in human nutrition projected for 2050 and simultaneously reduce many of the negative impacts our current food production system has on climate and the global environment. What most surprised or interested you about your findings? We always knew that the high productivity of marine microalgae could help us reduce the carbon and land footprints of agriculture. However, what came as an unexpected surprise was just how much protein could potentially be produced from such a small footprint of non-arable, coastal land in the Global South. The implications of our results for sustainable development are profound. What are the next steps for research on this topic? As green venture capitalist John Doerr emphasizes in his recent book*, it’s all about speed and scale. Our window of time to solve these global challenges is narrow, and the solutions are on a scale that our policymakers have difficulty even imagining, let alone investing in. The future of algae-based solutions in achieving global food security and environmental sustainability will depend on the actions taken by the investment community and governments today. *Speed & Scale: An Action Plan for Solving Our Climate Crisis Now Reference: “Algal solutions: Transforming marine aquaculture from the bottom up for a sustainable future” by Charles H. Greene and Celina M. Scott-Buechler, 17 October 2022, PLOS Biology. DOI: 10.1371/journal.pbio.3001824

Three-dimensional model of the only known picrodontid skull in top (left) and bottom (right) views. CT scan technology revealed previously unknown bones of the skull (colored on the right) that helped demonstrate that picrodontids are not primates as previously believed. Credit: Jordan Crowell A student and a professor from CUNY’s Graduate Center and Brooklyn College have pruned a branch off the primate tree. New research reveals that picrodontids, small extinct mammals, are not related to primates. This discovery, made by examining a picrodontid skull with advanced CT scans, overturns decades of assumptions and highlights the impact of modern technology in paleontology. A research paper published in Royal Society’s Biology Letters on January 10 has revealed that picrodontids —an extinct family of placental mammals that lived several million years after the extinction of the dinosaurs—are not primates as previously believed. The paper—co-authored by Jordan Crowell, an Anthropology Ph.D. candidate at the CUNY Graduate Center; Stephen Chester, an Associate Professor of Anthropology at Brooklyn College and the Graduate Center; and John Wible, Curator of Mammals at the Carnegie Museum of Natural History— is significant in that it settled a paleontological debate that has been brewing for over 100 years while helping to paint a more clear picture of primate evolution. Rethinking Picrodontids’ Classification For the last 50 years, paleontologists have believed picrodontids, which were no larger than a mouse and likely ate foods such as fruit, nectar, and pollen, were primates, based on features of their teeth that they share with living primates. But by using modern CT scan technology to analyze the only known preserved picrodontid skull in Brooklyn College’s Mammalian Evolutionary Morphology Laboratory, Crowell, the lead author on the paper, worked with Chester, the paper’s senior author, and Wible to determine they are not closely related to primates at all. Jordan Crowell, an Anthropology Ph.D. candidate at the CUNY Graduate Center worked with modern CT scan technology to analyze the picrodontid skull in Brooklyn College’s Mammalian Evolutionary Morphology Laboratory. Credit: Richard Petrias Independent Evolutionary Traits “While picrodontids share features of their teeth with living primates, the bones of the skull, specifically the bone that surrounds the ear, are unlike that of any living primate or close fossil relatives of primates,” Crowell said. “This suggests picrodontids and primates independently evolved similarities of their teeth likely for similar diets. This study also highlights the importance of revisiting old specimens with updated techniques to examine them.” Historical Context and Technological Advances Chester, who serves as Crowell’s Ph.D. adviser, has both a professional and personal interest in this research. It was Chester’s renowned colleague and “academic grandfather,” Professor Emeritus Frederick Szalay from CUNY’s Hunter College and the Graduate Center, who in 1968 first convincingly classified picrodontids as primates based on evidence from fossilized teeth. Szalay studied the teeth of the only known picrodontid skull, Zanycteris paleocenus, for his research—the same skull this team examined with the new technology that led to their discovery. “The Zanycteris cranium was prepared and partially submerged in plaster around 1917, so researchers studying this important specimen at the American Museum of Natural History were not aware of how much cranial anatomy was hidden over the last 100 years,” Chester said. “Micro-CT scanning has revolutionized the field of paleontology and allows researchers to discover so much more about previously studied fossils housed in natural history museum collections.” Reference: “Basicranial evidence suggests picrodontid mammals are not stem primates” by Jordan W. Crowell, John R. Wible and Stephen G. B. Chester, 10 January 2024, Biology Letters. DOI: 10.1098/rsbl.2023.0335 The research was funded by grants Chester and Crowell secured through Brooklyn College from the National Science Foundation and The Leakey Foundation. Chester and Crowell are also currently working on several additional externally funded research projects focused on how primates and other mammals evolved following the extinction of the dinosaurs. They encourage undergraduates to contact them regarding funded research opportunities in the Mammalian Evolutionary Morphology Laboratory.

An international research team has identified key base pairs in the human genome that remained consistent over millions of years of mammalian evolution, which play a significant role in human disease, highlighting genetic regions where mutations are not tolerated in evolution, a breakthrough that could improve our understanding of disease origins and inform future genetic research. Base Pairs of DNA That Play a Vital Role in Human Disease Have Been Identified by a Researcher From USC Dr. Steven Gazal, an assistant professor of population and public health sciences at the Keck School of Medicine of USC, is on a mission to answer a perplexing question: Why, despite millions of years of evolution, do humans still suffer from diseases? As part of an international research team, Gazal has made a groundbreaking discovery. They’ve become the first to accurately pinpoint specific base pairs in the human genome that have remained unaltered throughout millions of years of mammalian evolution. These base pairs play a significant role in human disease. Their findings were published in a special Zoonomia edition of the journal Science. Gazal and his team analyzed the genomes of 240 mammals, including humans, zooming in with unprecedented resolution to compare DNA. They were able to identify base pairs that were “constrained” – meaning they remained generally consistent – across mammal species over the course of evolution. Individuals born with mutations on these genes may not have been as successful within their species or were otherwise not likely to pass down the genetic variation. “We were able to identify where gene mutations are not tolerated in evolution, and we demonstrated that these mutations are significant when it comes to disease,” explains Gazal. The Significance of Evolutionary Constraints on Disease The team found that 3.3% of bases in the human genome are “significantly constrained,” including 57.6% of the coding bases that determine amino acid position, meaning these bases had unusually few variants across species in the dataset. The most constrained base pairs in mammals were over seven times more likely to be causal for human disease and complex traits, and over 11 times more likely when researchers looked at the most constrained base pairs in primates alone. The dataset was provided by the Zoonomia consortium, which according to the project website, “is applying advances in DNA sequencing technologies to understand how genomes generate the tremendous wealth of animal diversity.” Gazal gives credit to Zoonomia for making this type of data available to researchers and anticipates it will be widely used by human geneticists. “It’s a cheap resource to generate, as opposed to datasets generated in human genetic studies,” says Gazal. His team’s findings are a significant step forward, as Gazal notes, “We do not understand 99% of the human genome, so it is fundamental to understand which part has been constrained by evolution and is likely to have an impact on human phenotypes.” Their discoveries and methods could become crucial tools for further research. The next step for Gazal and his team is to repeat the process with a primate-only dataset. By restricting the subjects, they hope to focus on functions of DNA that appeared more recently in human evolution. “We expect this to be even more useful in determining information on human disease,” says Gazal. Reference: “Leveraging base-pair mammalian constraint to understand genetic variation and human disease” by Patrick F. Sullivan, Jennifer R. S. Meadows, Steven Gazal, BaDoi N. Phan, Xue Li, Diane P. Genereux, Michael X. Dong, Matteo Bianchi, Gregory Andrews, Sharadha Sakthikumar, Jessika Nordin, Ananya Roy, Matthew J. Christmas, Voichita D. Marinescu, Chao Wang, Ola Wallerman, James Xue, Shuyang Yao, Quan Sun, Jin Szatkiewicz, Jia Wen, Laura M. Huckins, Alyssa Lawler, Kathleen C. Keough, Zhili Zheng, Jian Zeng, Naomi R. Wray, Yun Li, Jessica Johnson, Jiawen Chen, Zoonomia Consortium§. , Benedict Paten, Steven K. Reilly, Graham M. Hughes, Zhiping Weng, Katherine S. Pollard, Andreas R. Pfenning, Karin Forsberg-Nilsson, Elinor K. Karlsson, Kerstin Lindblad-Toh, Gregory Andrews, Joel C. Armstrong, Matteo Bianchi, Bruce W. Birren, Kevin R. Bredemeyer, Ana M. Breit, Matthew J. Christmas, Hiram Clawson, Joana Damas, Federica Di Palma, Mark Diekhans, Michael X. Dong, Eduardo Eizirik, Kaili Fan, Cornelia Fanter, Nicole M. Foley, Karin Forsberg-Nilsson, Carlos J. Garcia, John Gatesy, Steven Gazal, Diane P. Genereux, Linda Goodman, Jenna Grimshaw, Michaela K. Halsey, Andrew J. Harris, Glenn Hickey, Michael Hiller, Allyson G. Hindle, Robert M. Hubley, Graham M. Hughes, Jeremy Johnson, David Juan, Irene M. Kaplow, Elinor K. Karlsson, Kathleen C. Keough, Bogdan Kirilenko, Klaus-Peter Koepfli, Jennifer M. Korstian, Amanda Kowalczyk, Sergey V. Kozyrev, Alyssa J. Lawler, Colleen Lawless, Thomas Lehmann, Danielle L. Levesque, Harris A. Lewin, Xue Li, Abigail Lind, Kerstin Lindblad-Toh, Ava Mackay-Smith, Voichita D. Marinescu, Tomas Marques-Bonet, Victor C. Mason, Jennifer R. S. Meadows, Wynn K. Meyer, Jill E. Moore, Lucas R. Moreira, Diana D. Moreno-Santillan, Kathleen M. Morrill, Gerard Muntané, William J. Murphy, Arcadi Navarro, Martin Nweeia, Sylvia Ortmann, Austin Osmanski, Benedict Paten, Nicole S. Paulat, Andreas R. Pfenning, BaDoi N. Phan, Katherine S. Pollard, Henry E. Pratt, David A. Ray, Steven K. Reilly, Jeb R. Rosen, Irina Ruf, Louise Ryan, Oliver A. Ryder, Pardis C. Sabeti, Daniel E. Schäffer, Aitor Serres, Beth Shapiro, Arian F. A. Smit, Mark Springer, Chaitanya Srinivasan, Cynthia Steiner, Jessica M. Storer, Kevin A. M. Sullivan, Patrick F. Sullivan, Elisabeth Sundström, Megan A. Supple, Ross Swofford, Joy-El Talbot, Emma Teeling, Jason Turner-Maier, Alejandro Valenzuela, Franziska Wagner, Ola Wallerman, Chao Wang, Juehan Wang, Zhiping Weng, Aryn P. Wilder, Morgan E. Wirthlin, James R. Xue and Xiaomeng Zhang, 28 April 2023, Science. DOI: 10.1126/science.abn2937 The study was funded by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Cancer Society, the Swedish Childhood Cancer Fund, the National Institute of Mental Health, the Gladstone Institutes, the National Institute on Drug Abuse, University College Dublin (UCD) Ad Astra Fellowship, and the National Human Genome Research Institute.

DVDV1551RTWW78V